Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Implicit Bioscience

Implicit Bioscience?uq=BoBgMMEs
2002 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Angel LATEST DEAL TYPE
$125K LATEST DEAL AMOUNT
Description

Operator of a clinical-stage drug development company intended to discover drugs for inflammatory and infectious diseases. The company's clinical-stage drug development service develops drugs that modulate the host immune response to disease and it develops small molecule dipeptide oglufanide disodium for community and hospital-acquired infections including those caused by bio-threat agents, enabling doctors to treat inflammatory and infectious diseases.

Formerly Known As
Melmotte
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • James Tower, Suite 235
  • 550 17th Avenue
  • Seattle, WA 98122
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Implicit Bioscience’s full profile, request a free trial.

Implicit Bioscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 13-Sep-2017 $125K 00000 Completed Generating Revenue
2. Angel (individual) 15-Sep-2016 00000 00000 Completed Generating Revenue
1. Angel (individual) 16-Nov-2015 $50.8K $50.8K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Implicit Bioscience Executive Team (7)

Name Title Board
Seat
Contact
Info
Marion Koster Chief Financial Officer and Company Secretary
Garry Redlich Co-Founder, Managing Director, Chief Executive Officer and Board Member
Jim Rottsolk Director and Chairman
Ian Frazer Director & Chairman, Scientific Advisory Board
Brian Ziegelaar Ph.D Chief Business Officer

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »

Implicit Bioscience Board Members (9)

Name Representing Role Since Contact
Info
Daniel Syrdal Ph.D Implicit Bioscience Board Member 000 0000
Garry Redlich Implicit Bioscience Co-Founder, Managing Director, Chief Executive Officer and Board Member 000 0000
Ian Frazer Implicit Bioscience Director & Chairman, Scientific Advisory Board 000 0000
Jim Rottsolk Implicit Bioscience Director and Chairman 000 0000
Lee Huntsman Implicit Bioscience Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 9 board members. Get the full list »